Beilu Pharma: Iodinated Methylpyrrolidone Chemical Raw Material Approved for Market Launch
I'm PortAI, I can summarize articles.
Beilu Pharma's subsidiary Zhejiang Haichang Pharmaceutical recently received approval from the National Medical Products Administration for the market launch of Iopamidol chemical raw materials. Iopamidol is a low-osmolar, non-ionic water-soluble contrast agent widely used in CT enhancement imaging and angiography, particularly suitable for patients with renal insufficiency and high-risk patients. Due to its excellent imaging effect and lower side effects, it has become one of the preferred contrast agents in clinical practice
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments